Article
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Field Medical Execution Despite Limited Resources
Summary
In this episode, Ed Cunningham delves into his extensive background in Neurology MSLs and shares insights on managing MSL teams, including the role of outsourcing. He explores the impact of virtual platforms and technology on MSL interactions, and offers strategies for engaging KOLs in the post-COVID landscape. Ed addresses the challenges of maintaining effectiveness in large territories, and discusses metrics for performance measurement in Medical Affairs. The conversation extends to the future of the MSL role, hybrid work models, and the evolving value of MSLs to stakeholders. The episode concludes with closing remarks and sponsorship from Synovian Pharmaceuticals.
My guest today is Ed Cunningham, Executive Director, Neurology MSLs with Sunovian Pharmaceuticals shares insights for Field Medical Execution Despite Limited Resources
Ed discusses…
👉 How to lead MSL teams with limited resources
👉 The importance of outsourcing to support field-based efforts and activities
👉 Virtual and alternative platforms to share data and gather insights
👉 What are best practices for prioritizing KOL engagement and tracking
👉 How budget plays a factor
👉 How an MSL can maintain effectiveness in a very large territory
👉 How an MSL can adapt a territory plan to accomplish objectives
Neurology MSLs, managing MSL teams, virtual platforms impact, engaging KOLs strategies, future of MSL role
Related Topics
You May Also Like
Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD
Podcast
Michael Pietrack
Hiring Managers Beware: Reverse Rejection Explained!
Article
Jamie Riley
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Forbes Books Press Release Official
New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures
Podcast
MSL Talk: Tom Caravela, Josh Corriveau